Mutational analysis of the p53 and K-ras genes and allelotype study of the Rb-1 gene for investigating the pathogenesis of combined hepatocellular-cholangiocellular carcinomas

Japanese Journal of Cancer Research

Volumn 87, Issue 10, 1996, Pages 1056-1062

  Imai, Yasuo ^a   Oda, Hideaki ^a   Arai, Masami ^a   Shimizu, Seiichiro ^a   Nakatsuru, Yoko ^a   Inoue, Tohru ^b   Ishikawa, Takatoshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b TOKYO KOSEI NENKIN HOSPITAL   (Japan)

Author keywords

Combined hepatocellular cholangiocellular carcinoma; K ras; Keratin; p53; Rb 1

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; KERATIN; PROTEIN P53;

ALLELE; ARTICLE; AUTOPSY; BILE DUCT CARCINOMA; CELL TRANSFORMATION; CLINICAL ARTICLE; CODON; EPITHELIUM; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; ONCOGENE K RAS; PHENOTYPE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0029827250     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1996.tb03110.x     Document Type: Article

References (27)

1. Aoki, K., Takayasu, K., Kawano, T., Muramatsu, Y., Moriyama, N., Wakao, F., Yamamoto, J., Shimada, K., Takayama, T., Kosuge, T., Yamasaki, S., Sakamoto, M. and Hirohashi, S. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features and computed tomographic findings. Hepatology, 18, 1090-1095 (1993).
2. Edmondson, H. A. and Peters, R. L. Neoplasms of the liver. In "Diseases of the Liver, 5th Ed.," ed. L. Schiff, E. R. Schiff, p. 1101 (1982). J. B. Lippincott, Philadelphia.
3. Nakahara, T. A clinicopathological study of combined hepatocellular-cholangiocellular carcinoma. Acta Hepatol. Jpn., 27, 1431-1438 (1986).
4. Tobe, R., Okuda, K., Sasaki, H., Shikata, T., Sugawara, K., Totsuki, T., Nakajima, T., Hattori, S., Mizumoto, R. and Mori, W. The 8th report. Acta Hepatol. Jpn., 29, 1619-1626 (1988).
5. Uekusa, T. A immunohistochemical study of combined hepatocellular-cholangiocellular carcinoma. Acta Hepatol. Jpn., 27, 343-353 (1987).
6. Fisher, H. P., Doppl, W., Osbern, M. and Altmannsberger, M. Evidence for a hepatocellular lineage in a combined hepatocellular-cholangiocarcinoma of transitional type. Virchow Archiv. B Cell Pathol., 56, 71-76 (1988).
7. van Eyken, P., Sciot, R., Paterson, A., Callea, F., Kew, M. C. and Desmet, V. J. Cytokeratine expression in hepatocellular carcinoma: an immunohistochemical study. Hum. Pathol., 19, 562-568 (1988).
8. Goodman, Z. D., Ishak, K. G., Langloss, J. M., Sesterhenn, I. A. and Rabin, I. Combined hepatocellular-cholangiocarcinoma. A histologic and immunohistochemical study. Cancer, 58, 124-135 (1985).
9. Oda, T., Tsuda, H., Scarpa, A., Sakamoto, M. and Hirohashi, S. Mutation pattern of the p53 gene as a diagnostic marker for multiple hepatocellular carcinoma. Cancer Res., 52, 3674-3678 (1992).
10. Hsu, H. C., Chiou, T. J., Chen, J. Y., Lee, C. S., Lee, P. H. and Peng, S. Y. Clonality and clonal evolution of hepatocellular carcinoma with multiple nodules. Hepatology, 13, 923-928 (1991).
11. Murakami, Y., Hayashi K., Hirohashi, S. and Sekiya, T. Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinoma. Cancer Res., 51, 5520-5525 (1991).
12. Nishida, N., Fukuda, Y., Kokuryu, H., Sadamoto, T., Isowa, G., Honda, K., Yamaoka, Y., Ikenaga, M., Imura, H. and Ishizaki, K. Accumulation of allelic loss on arms of chromosomes 13q, 16q and 17p in the advanced stages of human hepatocellular carcinoma. Int. J. Cancer, 51, 862-868 (1992).
13. Ohashi, K., Nakajima, Y., Kanehiro, H., Tsutsumi, M., Taki, J., Aomatsu, Y., Yoshimura, A., Ko, S., Kin, T., Yagura, K., Konishi, Y. and Nakano, H. Ki-ras mutations and p53 expressions in intrahepatic cholangiocarcinomas: relation to gross tumor morphology. Gastroenterology, 109, 1612-1617 (1995).
14. Tada, M., Omata, M. and Ohto, M. Analysis of ras gene mutations in human hepatic malignant tumors by polymerase chain reactions and direct sequencing. Cancer Res., 50, 1121-1124 (1990).
15. Walker, G. J., Hayward, N. K., Falvey, S. and Cooksley, W. G. E. Loss of somatic heterozygosity in hepatocellular carcinoma. Cancer Res., 51, 4367-4370 (1991).
16. Zhang, X., Xu, H.J., Murakami, Y., Sachse, R., Yashima, K., Hirohashi, S., Hu, S.-X., Benedict, W. F. and Sekiya, T. Deletions of chromosome 13q, mutations in Retinoblastoma 1, and retinoblastoma protein state in human hepatocellular carcinomas. Cancer Res., 54, 4177-4182 (1994).
17. Tsuda, H., Satarug, S., Bhudhisawasdi, V., Kihana, T., Sugimura, T. and Hirohashi, S. Cholangiocarcinomas in Japanese and Thai patients: difference in etiology and incidence of point mutation of the c-Ki-ras protooncogene. Mol. Carcinog., 6, 266-269 (1992).
18. Allen, R. A. and Lisa, J. R. Combined liver cell and bile duct carcinoma. Am. J. Pathol., 25, 647-655 (1949).
19. Liver Cancer Study Group of Japan. "The General Rules for the Clinical and Pathological Study of Primary Liver Cancer, 3rd Ed.," p. 41 (1992). Kanehara Co., Tokyo.
20. Imprain, C. C., Saiki, R. K., Erlich, H. A. and Teplitz, R. L. Analysis of DNA extracted from formalin-fixed, paraffin-embedded tissue by enzymatic amplification and hybridization with sequence-specific oligonucleotides. Biochem. Biophys. Res. Commun., 142, 710-716 (1987).
21. Cawkwell, L., Lewis, F. A. and Quirke, P. Frequency of allele loss of DCC, p53, RB1, WT1, NF1, NM23 and APC/MCC in colorectal cancer assayed by fluorescent multiplex polymerase chain reaction. Br. J. Cancer, 70, 813-818 (1994).
22. Hsu, I. C., Metcalf, R. A., Sun, T., Welsh, J. A. and Harris, C. C. Mutational hotspot in the p53 gene in human hepatocellular carcinoma. Nature, 350, 427-428 (1991).
23. McGee, T. L., Yandell, D. W. and Dryja, T. P. Structure and partial genomic sequence of the human retinoblastoma susceptibility gene. Gene, 80, 119-128 (1989).
24. McGraph, J. P., Capon, D. J., Smith, D. H., Chen, E. Y., Seeburg, P. H., Goeddel, D. V. and Levinson, A. D. Structure and organization of the human Ki-ros protooncogene and a related processed pseudogene. Nature, 304, 501-506 (1983).
25. Call, K. M., Glaser, T., Ito, C. Y., Buckler, A. J., Pelletier, J., Haber, D. A., Rose, E. A., Krai, A., Yeger, H., Lewis, W. H., Jones, C. and Housman, D. E. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilm's tumor locus. Cell, 60, 509-520 (1990).
26. Nigro, J. M., Baker, S. J., Preisinger, A. C., Jessup, J. M., Hostetter, R., Cleary, K., Binger, S. H., Davidson, N., Baylin, S., Devilee, P., Glover, T., Collins, F. S., Weslon, A., Modali, R., Harris, C. C. and Vogelstein, B. Mutations in the p53 gene occur in diverse human tumor types. Nature, 342, 705-708 (1989).
27. Hsu, S. M., Raine, L. and Ranger, H. Use of avidin-biotin peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabelled antibody (PAP) procedures. J. Histochem. Cytochem., 29, 557-580 (1981).